Total Payments
$8,331
2024 Payments
$1,397
Companies
29
Transactions
467
Medicare Patients
12,987
Medicare Billing
$920,164
Payment Breakdown by Category
Food & Beverage$8,044 (96.5%)
Education$287.43 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,044 | 463 | 96.5% |
| Education | $287.43 | 4 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,146 | 118 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,139 | 70 | $0 (2024) |
| Lilly USA, LLC | $759.35 | 45 | $0 (2024) |
| LEO Pharma Inc. | $517.18 | 36 | $0 (2024) |
| GENZYME CORPORATION | $433.10 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $407.81 | 17 | $0 (2024) |
| PFIZER INC. | $381.52 | 26 | $0 (2023) |
| Amgen Inc. | $364.29 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $303.45 | 13 | $0 (2024) |
| Incyte Corporation | $290.89 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,397 | 68 | ABBVIE INC. ($483.29) |
| 2023 | $1,814 | 103 | ABBVIE INC. ($399.76) |
| 2022 | $1,626 | 77 | ABBVIE INC. ($321.16) |
| 2021 | $1,186 | 81 | Novartis Pharmaceuticals Corporation ($285.55) |
| 2020 | $552.85 | 34 | AbbVie Inc. ($153.01) |
| 2019 | $780.79 | 42 | AbbVie, Inc. ($336.84) |
| 2018 | $517.77 | 31 | AbbVie, Inc. ($221.49) |
| 2017 | $455.98 | 31 | LEO Pharma Inc. ($146.33) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.07 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.21 | General |
| 10/08/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: DERMATOLOGY | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,282 | 6,016 | $1.2M | $240,062 |
| 2022 | 23 | 3,189 | 5,964 | $1.1M | $210,646 |
| 2021 | 26 | 3,343 | 6,382 | $1.1M | $233,010 |
| 2020 | 22 | 3,173 | 6,000 | $874,181 | $236,446 |
Total Patients
12,987
Total Services
24,362
Medicare Billing
$920,164
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 556 | 740 | $219,780 | $44,272 | 20.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 368 | 443 | $167,454 | $34,462 | 20.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 539 | 737 | $164,351 | $26,601 | 16.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 299 | 346 | $116,948 | $22,141 | 18.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 398 | 491 | $91,326 | $18,223 | 20.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 401 | 2,392 | $55,016 | $11,684 | 21.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 74 | 92 | $51,704 | $11,296 | 21.8% |
| 17108 | Destruction of birthmark, more than 50.0 sq cm | Office | 2023 | 11 | 23 | $48,139 | $10,561 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 132 | 132 | $48,708 | $9,449 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 95 | $39,900 | $8,006 | 20.1% |
| 17107 | Destruction of birthmark, 10.0-50.0 sq cm | Office | 2023 | 12 | 22 | $32,472 | $7,632 | 23.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $28,300 | $6,091 | 21.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 40 | $23,760 | $4,889 | 20.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $17,248 | $4,050 | 23.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 28 | 37 | $16,317 | $3,436 | 21.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 62 | 86 | $14,448 | $3,340 | 23.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 51 | 51 | $12,138 | $2,492 | 20.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 26 | 26 | $10,894 | $2,247 | 20.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 42 | 44 | $13,376 | $2,159 | 16.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $17,073 | $1,894 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,752 | $1,832 | 20.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $10,668 | $1,252 | 11.7% |
| 69100 | Biopsy of ear | Office | 2023 | 24 | 26 | $8,346 | $1,069 | 12.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 17 | $3,230 | $510.88 | 15.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 24 | $1,128 | $219.79 | 19.5% |
About Dr. Michaela Overturf, MD
Dr. Michaela Overturf, MD is a Dermatology healthcare provider based in Nacogdoches, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2011. The National Provider Identifier (NPI) number assigned to this provider is 1144514803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michaela Overturf, MD has received a total of $8,331 in payments from pharmaceutical and medical device companies, with $1,397 received in 2024. These payments were reported across 467 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($8,044).
As a Medicare-enrolled provider, Overturf has provided services to 12,987 Medicare beneficiaries, totaling 24,362 services with total Medicare billing of $920,164. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Nacogdoches, TX
- Active Since 05/30/2011
- Last Updated 07/21/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1144514803
Products in Payments
- COSENTYX (Biological) $803.07
- SKYRIZI (Biological) $785.51
- DUPIXENT (Biological) $782.40
- TALTZ (Drug) $743.32
- RINVOQ (Biological) $630.97
- Humira (Biological) $456.33
- TREMFYA (Drug) $417.39
- EUCRISA (Drug) $381.52
- Otezla (Drug) $346.69
- COSENTYX (Drug) $290.38
- Sotyktu (Drug) $287.74
- OPZELURA (Drug) $277.29
- PICATO (Drug) $207.65
- ENSTILAR (Drug) $171.66
- Seysara (Drug) $154.96
- ADBRY (Biological) $137.87
- HUMIRA (Biological) $131.31
- Skyrizi (Biological) $98.67
- Winlevi (Drug) $85.80
- Zoryve (Drug) $81.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.